/PRNewswire/ BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that positive new data supporting the safety and efficacy of VOXZOGO® (vosoritide) in.
Somatotropin Deficiency Pipeline Assessment (2023) Covering openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.
Pfizer (PFE) and OPKO (OPK) Announce FDA Approval of NGENLA streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ According to a recent market study published by Growth Market Reports, titled, "Global Synthetic Human Secretin Market Segments - By Types.